title: Remifentanil and acute intermittent porphyria.
authors.forename: M
authors.initials: M
authors.lastname: Durmus
authors.forename: A
authors.initials: A
authors.lastname: Turkoz
authors.forename: T
authors.initials: T
authors.lastname: Togal
authors.forename: A
authors.initials: A
authors.lastname: Koroglu
authors.forename: H I
authors.initials: HI
authors.lastname: Toprak
authors.forename: M O
authors.initials: MO
authors.lastname: Ersoy
mesh_terms: D000328:Adult; D000701:Analgesics, Opioid / Q000009:adverse effects; D000768:Anesthesia, General / Q000379:methods*; D000773:Anesthesia, Obstetrical / Q000379:methods*; D018686:Anesthetics, Intravenous / Q000009:adverse effects; D002585:Cesarean Section; D004630:Emergencies; D005260:Female; D006801:Humans; D010880:Piperidines / Q000009:adverse effects; D017118:Porphyria, Acute Intermittent; D011247:Pregnancy; D011248:Pregnancy Complications; D000077208:Remifentanil
chemical_list: D000701:Analgesics, Opioid; D018686:Anesthetics, Intravenous; D010880:Piperidines; D000077208:Remifentanil